Stock Analysis
- United States
- /
- Chemicals
- /
- NYSE:NGVT
Ingevity First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Ingevity (NYSE:NGVT) First Quarter 2024 Results
Key Financial Results
- Revenue: US$340.1m (down 13% from 1Q 2023).
- Net loss: US$56.0m (down by 211% from US$50.7m profit in 1Q 2023).
- US$1.54 loss per share (down from US$1.36 profit in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ingevity Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 6.6%. Earnings per share (EPS) missed analyst estimates.
Looking ahead, revenue is expected to decline by 1.5% p.a. on average during the next 3 years, while revenues in the Chemicals industry in the US are expected to grow by 4.8%.
Performance of the American Chemicals industry.
The company's shares are up 14% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 1 warning sign for Ingevity you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Ingevity is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:NGVT
Ingevity
Manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America.
Fair value with moderate growth potential.